The fetal safety of thiopurines for the treatment of inflammatory bowel disease in pregnancy

Author： Hutson J. R.   Matlow J. N.   Moretti M. E.   Koren G.  

Publisher： Informa Healthcare

ISSN： 1364-6893

Source： Journal of Obstetrics & Gynaecology, Vol.33, Iss.1, 2013-01, pp. : 1-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inflammatory bowel disease: management issues during pregnancy

By Ferrero Simone  

Archives of Gynecology and Obstetrics, Vol. 270, Iss. 2, 2004-09 ,pp. : 79-85

Springer Publishing Company

Access to resources Recommend Favorite

Inflammatory bowel disease: risk factors for adverse pregnancy outcome and the impact of maternal weight gain

By Oron Galia   Yogev Yariv   Shkolnik Smadar   Hod Moshe   Fraser Gerald   Wiznitzer Arnon   Melamed Nir  

Journal of Maternal-Fetal and Neonatal Medicine, Vol. 25, Iss. 11, 2012-11 ,pp. : 2256-2260

Informa Healthcare

Access to resources Recommend Favorite

Perinatal outcomes in inflammatory bowel disease

By Bush MC   Patel S   Lapinski RH   Stone JL  

Journal of Maternal-Fetal and Neonatal Medicine, Vol. 15, Iss. 4, 2004-04 ,pp. : 237-241

Informa Healthcare

Access to resources Recommend Favorite

Inflammatory bowel disease and preterm delivery

By Wispelwey Bram   Sheiner Eyal  

Archives of Gynecology and Obstetrics, Vol. 288, Iss. 4, 2013-10 ,pp. : 725-730

Springer Publishing Company

Access to resources Recommend Favorite

Pelvic inflammatory disease: medical treatment

By Quentin R.   Lansac J.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 92, Iss. 2, 2000-10 ,pp. : 189-192

Elsevier

Access to resources Recommend Favorite